Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chaihu Shengjiang Fang (柴胡升降方) is a Traditional Chinese Medicine (TCM) herbal formula. The name translates to "Bupleurum Ascending and Descending Formula," indicating its primary therapeutic aim is to regulate the ascending and descending movement of Qi (vital energy) within the body, a fundamental concept in TCM. While a precise, universally standardized composition for "Chaihu Shengjiang Fang" is not readily available, it is understood to be a formula that prominently features Chaihu (Bupleurum root) and likely includes Shengjiang (fresh ginger). Chaihu is a key herb in TCM known for its ability to soothe liver Qi stagnation, disperse heat and fever, and raise Yang Qi. Modern pharmacological studies on Chaihu and its active components, saikosaponins, have revealed immunomodulatory, antiviral, antipyretic, hepatoprotective, anticancer, sedative, and analgesic effects, as well as the ability to induce autophagy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chaihu Shengjiang Fang.